Search by Drug Name or NDC
NDC 52544-0295-28 Amethyst 20; 90 ug/1; ug/1 Details
Amethyst 20; 90 ug/1; ug/1
Amethyst is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is ETHINYL ESTRADIOL; LEVONORGESTREL.
Product Information
| NDC | 52544-0295 |
|---|---|
| Product ID | 52544-295_ed1b659f-b9be-4ce6-8751-8e5e26a8f195 |
| Associated GPIs | 25994002350320 |
| GCN Sequence Number | 062777 |
| GCN Sequence Number Description | levonorgestrel/ethin.estradiol TABLET 90-20 MCG ORAL |
| HIC3 | G8A |
| HIC3 Description | CONTRACEPTIVES,ORAL |
| GCN | 98551 |
| HICL Sequence Number | 001460 |
| HICL Sequence Number Description | LEVONORGESTREL/ETHINYL ESTRADIOL |
| Brand/Generic | Generic |
| Proprietary Name | Amethyst |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Levonorgestrel and Ethinyl Estradiol |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 20; 90 |
| Active Ingredient Units | ug/1; ug/1 |
| Substance Name | ETHINYL ESTRADIOL; LEVONORGESTREL |
| Labeler Name | Actavis Pharma, Inc. |
| Pharmaceutical Class | Estrogen Receptor Agonists [MoA], Estrogen [EPC], Inhibit Ovum Fertilization [PE], Progesterone Congeners [CS], Progesterone Congeners [CS], Progestin [EPC], Progestin-containing Intrauterine Device [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA079218 |
| Listing Certified Through | n/a |
Package
NDC 52544-0295-28 (52544029528)
| NDC Package Code | 52544-295-28 |
|---|---|
| Billing NDC | 52544029528 |
| Package | 1 POUCH in 1 CARTON (52544-295-28) / 1 BLISTER PACK in 1 POUCH / 28 TABLET in 1 BLISTER PACK |
| Marketing Start Date | 2011-06-13 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 1.05281 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | AMETHYST 90-20 MCG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis